CytomX Therapeutics CTMX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's quick ratio?
- CytomX Therapeutics (CTMX) reported quick ratio of 10.4× in Q1 2026.
- How has CytomX Therapeutics's quick ratio changed year-over-year?
- CytomX Therapeutics's quick ratio increased by 501.4% year-over-year, from 1.7× to 10.4×.
- What is the long-term trend for CytomX Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), CytomX Therapeutics's quick ratio has grown at a -8.3% compound annual growth rate (CAGR), from 4.8× to 3.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.